medical · Global
Queensland Minister rejects non-binding petition for Medical Cannabis driving law change - unsurprisingly…

🌿 Plant Truth Index
Factual Record
90+ Stigma Breaker · 70+ Plant Forward · 40+ Factual Record · below 40 Prohibition Echo
From the published response: I write in response to petition number 4319-26, tabled in Parliament on 23 April 2026. The Crisafulli Government takes a zero-tolerance approach to drug driving. In Queensland, a person who drives a motor vehicle while a \`relevant drug' is present in their blood or saliva commits an offence under Section 79(2AA) of the Transport Operations (Road Use Management) Act 1995 (Qld). Some medicinal cannabis products contain THC, the active ingredient in cannabis detected as a \`relevant drug' within Queensland's drug driving laws. I am advised THC is a psychoactive substance that has shown to impair cognitive and motor function and therefore increases the risk of being involved in a motor vehicle crash. I am advised that due to individual variability and the complexity of cannabinoid metabolism, definitive advice about the timing of administration to minimise the risk of impairment cannot be provided. In the absence of no reliable, widely accepted test to measure an individual's impairment from THC, governments rely on detectable-presence laws as a pre-cautionary measure. In prescribing medicinal cannabis, medical practitioners are required to obtain the info
From the published response: I write in response to petition number 4319-26, tabled in Parliament on 23 April 2026. The Crisafulli Government takes a zero-tolerance approach to drug driving. In Queensland, a person who drives a motor vehicle while a \`relevant drug' is present in their blood or saliva commits an offence under Section 79(2AA) of the Transport Operations (Road Use Management) Act 1995 (Qld). Some medicinal cannabis products contain THC, the active ingredient in cannabis detected as a \`relevant drug' within Queensland's drug driving laws. I am advised THC is a psychoactive substance that has shown to impair cognitive and motor function and therefore increases the risk of being involved in a motor vehicle crash. I am advised that due to individual variability and the complexity of cannabinoid metabolism, definitive advice about the timing of administration to minimise the risk of impairment cannot be provided. In the absence of no reliable, widely accepted test to measure an individual's impairment from THC, governments rely on detectable-presence laws as a pre-cautionary measure. In prescribing medicinal cannabis, medical practitioners are required to obtain the informed consent of the patient. This includes informing and ensuring patients understand that they cannot drive or operate machinery if the medicinal cannabis contains THC. The Work Health and Safety Act 2011 (Qld) sets out the requirements for healthy and safe workplaces and protections for the public. It also imposes significant penalties where an employer fails in their health and safety duty, if an employee is permitted to drive a vehicle or operate machinery, and an event occurs where an employee is exposed to the risk of, or actual death, injury or harm occurs in their workplace. Ultimately, if driving or operating machinery is an integral need for a patient, this should be part of the discussion between the patient and their health practitioner when prescribing medication. Thank you for raising this important matter with. Yours sincerely Tim Nicholls MP Minister for Health and Ambulance Services Member for Clayfield Source: https://www.parliament.qld.gov.au/Work-of-the-Assembly/Tabled-Papers/docs/5826T0759/5826t759.pdf submitted by /u/Hefty_Delay7765 [link] [comments]